Fatal venous thrombosis in hyperosmolar coma. 1971

Y Scharf, and M Nahir, and I Tatarsky, and J B Arieh, and G Baruch, and S Edelman

UI MeSH Term Description Entries
D009994 Osmolar Concentration The concentration of osmotically active particles in solution expressed in terms of osmoles of solute per liter of solution. Osmolality is expressed in terms of osmoles of solute per kilogram of solvent. Ionic Strength,Osmolality,Osmolarity,Concentration, Osmolar,Concentrations, Osmolar,Ionic Strengths,Osmolalities,Osmolar Concentrations,Osmolarities,Strength, Ionic,Strengths, Ionic
D011517 Prothrombin Time Clotting time of PLASMA recalcified in the presence of excess TISSUE THROMBOPLASTIN. Factors measured are FIBRINOGEN; PROTHROMBIN; FACTOR V; FACTOR VII; and FACTOR X. It is used for monitoring anticoagulant therapy with COUMARINS. Quick Test,Russell's Viper Venom Time,Thrombotest,Russell Viper Venom Time,Russells Viper Venom Time,Prothrombin Times,Test, Quick,Time, Prothrombin,Times, Prothrombin
D011655 Pulmonary Embolism Blocking of the PULMONARY ARTERY or one of its branches by an EMBOLUS. Pulmonary Thromboembolism,Thromboembolism, Pulmonary,Embolism, Pulmonary,Embolisms, Pulmonary,Pulmonary Embolisms,Pulmonary Thromboembolisms,Thromboembolisms, Pulmonary
D012082 Renal Veins Short thick veins which return blood from the kidneys to the vena cava. Renal Vein,Vein, Renal,Veins, Renal
D001778 Blood Coagulation Disorders Hemorrhagic and thrombotic disorders that occur as a consequence of abnormalities in blood coagulation due to a variety of factors such as COAGULATION PROTEIN DISORDERS; BLOOD PLATELET DISORDERS; BLOOD PROTEIN DISORDERS or nutritional conditions. Coagulation Disorders, Blood,Disorders, Blood Coagulation,Blood Coagulation Disorder,Coagulation Disorder, Blood,Disorder, Blood Coagulation
D003926 Diabetic Coma A state of unconsciousness as a complication of diabetes mellitus. It occurs in cases of extreme HYPERGLYCEMIA or extreme HYPOGLYCEMIA as a complication of INSULIN therapy. Coma, Diabetic,Comas, Diabetic,Diabetic Comas
D004211 Disseminated Intravascular Coagulation A disorder characterized by procoagulant substances entering the general circulation causing a systemic thrombotic process. The activation of the clotting mechanism may arise from any of a number of disorders. A majority of the patients manifest skin lesions, sometimes leading to PURPURA FULMINANS. Consumption Coagulopathy,Coagulation, Disseminated Intravascular,Disseminated Coagulation, Intravascular,Intravascular Coagulation, Disseminated,Intravascular Disseminated Coagulation,Coagulation, Intravascular Disseminated,Coagulations, Disseminated Intravascular,Coagulations, Intravascular Disseminated,Coagulopathies, Consumption,Coagulopathy, Consumption,Consumption Coagulopathies,Disseminated Coagulations, Intravascular,Disseminated Intravascular Coagulations,Intravascular Coagulations, Disseminated,Intravascular Disseminated Coagulations
D005260 Female Females
D005340 Fibrinogen Plasma glycoprotein clotted by thrombin, composed of a dimer of three non-identical pairs of polypeptide chains (alpha, beta, gamma) held together by disulfide bonds. Fibrinogen clotting is a sol-gel change involving complex molecular arrangements: whereas fibrinogen is cleaved by thrombin to form polypeptides A and B, the proteolytic action of other enzymes yields different fibrinogen degradation products. Coagulation Factor I,Factor I,Blood Coagulation Factor I,gamma-Fibrinogen,Factor I, Coagulation,gamma Fibrinogen
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Y Scharf, and M Nahir, and I Tatarsky, and J B Arieh, and G Baruch, and S Edelman
January 1975, Revista paulista de medicina,
Y Scharf, and M Nahir, and I Tatarsky, and J B Arieh, and G Baruch, and S Edelman
January 1987, Vutreshni bolesti,
Y Scharf, and M Nahir, and I Tatarsky, and J B Arieh, and G Baruch, and S Edelman
January 1974, Verhandlungen der Deutschen Gesellschaft fur Innere Medizin,
Y Scharf, and M Nahir, and I Tatarsky, and J B Arieh, and G Baruch, and S Edelman
April 1978, The New England journal of medicine,
Y Scharf, and M Nahir, and I Tatarsky, and J B Arieh, and G Baruch, and S Edelman
April 1999, Lancet (London, England),
Y Scharf, and M Nahir, and I Tatarsky, and J B Arieh, and G Baruch, and S Edelman
February 1969, Nederlands tijdschrift voor geneeskunde,
Y Scharf, and M Nahir, and I Tatarsky, and J B Arieh, and G Baruch, and S Edelman
September 1972, JAMA,
Y Scharf, and M Nahir, and I Tatarsky, and J B Arieh, and G Baruch, and S Edelman
December 1974, Medizinische Klinik,
Y Scharf, and M Nahir, and I Tatarsky, and J B Arieh, and G Baruch, and S Edelman
October 1968, The American journal of medicine,
Y Scharf, and M Nahir, and I Tatarsky, and J B Arieh, and G Baruch, and S Edelman
September 1968, Nederlands tijdschrift voor geneeskunde,
Copied contents to your clipboard!